{
    "Trade/Device Name(s)": [
        "NATtrol Vaginal Panel External Run Controls",
        "NATtrol BD MAX Vaginal Panel External Controls",
        "NATtrol BV Negative Control",
        "NATtrol BV Positive Control",
        "NATtrol Candida/TV Positive Control"
    ],
    "Submitter Information": "ZeptoMetrix, LLC",
    "510(k) Number": "K201403",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181683"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "May 26, 2020",
    "Summary Letter Received Date": "May 28, 2020",
    "Submission Date": "November 12, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "Lactobacillus crispatus",
        "Lactobacillus jensenii",
        "Gardnerella vaginalis",
        "Atopobium vaginae",
        "Saccharomyces cerevisiae",
        "BVAB2 (Bacterial Vaginosis-Associated Bacterium 2)",
        "Candida albicans",
        "Candida krusei",
        "Candida glabrata",
        "Trichomonas vaginalis"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD MAX System",
        "BD Vaginal Panel for BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing (qualitative detection)",
        "External run control"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material",
        "External run control"
    ],
    "Document Summary": "FDA 510(k) summary for ZeptoMetrix NATtrol BD MAX Vaginal Panel External Controls serving as assayed quality control material for monitoring nucleic acid testing procedures on the BD MAX System",
    "Indications for Use Summary": "Intended for use as assayed quality control material to monitor performance of in vitro diagnostic laboratory nucleic acid testing procedures for qualitative detection of panel targets on BD Vaginal Panel for BD MAX System; not intended to replace manufacturer controls",
    "fda_folder": "Microbiology"
}